P-2078. <i>Escherichia coli</i> Antimicrobial Resistance Risk Differences by Patient Demographics and Insurance Status in Rural Wisconsin

Abstract Background Our prior research demonstrated Escherichia coli antimicrobial resistance differences at a neighborhood level from 2009 to 2018. As a first step in explaining this variation, we investigated patient factors relating to antimicrobial resistance.Figure.Patient Demographics and Insurance Status Predict E. coli Non-susceptibility to Antibiotics: Results from Multivariable Logistic Regression Models Methods We conducted a retrospective analysis of patient demographics and E. coli antibiotic susceptibility from 2019 – 2024. Patients with a culture positive for E. coli and antibiotic susceptibility results at the Marshfield Clinic Health System were included. Patient-level variables analyzed included age, sex, race and ethnicity, type of insurance (public/private), farm residence (yes/no), and year of culture. We conducted logistic regression with generalized estimating equations analyses to identify predictors of E. coli susceptibility vs non-susceptibility (intermediate or resistant) to ciprofloxacin (CIP), nitrofurantoin (FM), trimethoprim/sulfamethoxazole (SXT), and ceftriaxone (CRO) as an indicator extended-spectrum beta-lactamase presence. Results Regression results are presented in the Figure. Compared to adults 18 to 64 years, children were significantly less likely to have E. coli non-susceptible to CIP and CRO. Older adults (≥65 years) were less likely to have E. coli non- susceptible to SXT but more likely to have E. coli non-susceptible to CIP and CTX compared to younger adults. Females were less likely to have E. coli non-susceptible to CIP and CRO than males. Compared to white patients, odds of E. coli non-susceptibility were higher for Hispanic (CIP, SXT, and FM) and non-white patients (CIP and SXT). Public insurance was a predictor of E. coli non-susceptibility to CIP and FM. Odds of non-susceptibility were higher in 2024 compared to 2019 for all antibiotics. Of 36,043 unique E. coli isolates, 1,642 (4.6%) were from farm-residing patients; however, farm residence was not significantly associated with E. coli susceptibility in multivariable models. Conclusion Children and female patients were at lower risk for non-susceptible E. coli. The risk of non-susceptibility was lower for SXT, and higher for CIP and CTX in older adults. Hispanic and non-white patients, and patients with public health insurance had greater risk for E. coli non-susceptibility. Disclosures Maria Sundaram, PhD, MSPH, GSK: Grant/Research Support Joshua Petrie, PhD, CSL Seqirus: Advisor/Consultant|CSL Seqirus: Grant/Research Support|ModernaTX: Grant/Research Support

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.2242
Primary Topic
Antibiotic Use and Resistance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-2078. Escherichia coli Antimicrobial Resistance Risk Differences by Patient Demographics and Insurance Status in Rural Wisconsin

Laurel Legenza, Taylor Wahlig, Sanjay K. Shukla, Thomas R. Fritsche et al.
Open Forum Infectious Diseases
Antibiotic Use and Resistance
article

P-2078. Escherichia coli Antimicrobial Resistance Risk Differences by Patient Demographics and Insurance Status in Rural Wisconsin

Laurel Legenza, Taylor Wahlig, Sanjay K. Shukla, Thomas R. Fritsche, Joshua Petrie, Maria Sundaram
article en

Abstract

Abstract Background Our prior research demonstrated Escherichia coli antimicrobial resistance differences at a neighborhood level from 2009 to 2018. As a first step in explaining this variation, we investigated patient factors relating to antimicrobial resistance.Figure.Patient Demographics and Insurance Status Predict E. coli Non-susceptibility to Antibiotics: Results from Multivariable Logistic Regression Models Methods We conducted a retrospective analysis of patient demographics and E. coli antibiotic susceptibility from 2019 – 2024. Patients with a culture positive for E. coli and antibiotic susceptibility results at the Marshfield Clinic Health System were included. Patient-level variables analyzed included age, sex, race and ethnicity, type of insurance (public/private), farm residence (yes/no), and year of culture. We conducted logistic regression with generalized estimating equations analyses to identify predictors of E. coli susceptibility vs non-susceptibility (intermediate or resistant) to ciprofloxacin (CIP), nitrofurantoin (FM), trimethoprim/sulfamethoxazole (SXT), and ceftriaxone (CRO) as an indicator extended-spectrum beta-lactamase presence. Results Regression results are presented in the Figure. Compared to adults 18 to 64 years, children were significantly less likely to have E. coli non-susceptible to CIP and CRO. Older adults (≥65 years) were less likely to have E. coli non- susceptible to SXT but more likely to have E. coli non-susceptible to CIP and CTX compared to younger adults. Females were less likely to have E. coli non-susceptible to CIP and CRO than males. Compared to white patients, odds of E. coli non-susceptibility were higher for Hispanic (CIP, SXT, and FM) and non-white patients (CIP and SXT). Public insurance was a predictor of E. coli non-susceptibility to CIP and FM. Odds of non-susceptibility were higher in 2024 compared to 2019 for all antibiotics. Of 36,043 unique E. coli isolates, 1,642 (4.6%) were from farm-residing patients; however, farm residence was not significantly associated with E. coli susceptibility in multivariable models. Conclusion Children and female patients were at lower risk for non-susceptible E. coli. The risk of non-susceptibility was lower for SXT, and higher for CIP and CTX in older adults. Hispanic and non-white patients, and patients with public health insurance had greater risk for E. coli non-susceptibility. Disclosures Maria Sundaram, PhD, MSPH, GSK: Grant/Research Support Joshua Petrie, PhD, CSL Seqirus: Advisor/Consultant|CSL Seqirus: Grant/Research Support|ModernaTX: Grant/Research Support

Open Forum Infectious DiseasesVol. 13(Supplement_1)
University of Wisconsin–Madison (US), Marshfield Clinic (US)
Openalex Percentile: Top 90%
Antibiotic Use and Resistance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.